Transforming neuroscience drug discovery

Blackbox Bio is a research technology company transforming preclinical neuroscience with its innovative rodent behavioral assessment platform. Founded in 2022 by Harvard neuroscientists Clifford Woolf, David Roberson, and Alex Zhang, the company integrates hardware, software, and machine learning to capture previously undetectable rodent behaviors. Their near-infrared imaging and proprietary OptitouchTM sensory technology enables precise assessment across models of pain, neurodegeneration, muscle disorders, voluntary behaviors, social interaction, and orthopedics.